Cantor Fitzgerald Bullish on HCA Healthcare and XBP Global in New Coverage

Key Facts

1Cantor Fitzgerald reiterated its Overweight rating for HCA Healthcare (NYSE:HCA) with a price target of $588.00.

2Cantor Fitzgerald initiated coverage of XBP Global (XBP) with an Overweight rating and a $5 price target.

3Analysts see upside potential in XBP's technology segment, particularly in agentic AI.

Cantor Fitzgerald has issued bullish updates for the healthcare and technology sectors, reiterating an 'Overweight' rating for HCA Healthcare with a price target of $588.00. Analysts believe HCA remains undervalued, citing positive EBITDA guidance for 2026 as a key growth driver. Simultaneously, the firm initiated coverage on XBP Global with an 'Overweight' rating and a $5.00 price target, identifying it as a compelling turnaround story. The optimistic outlook for XBP is largely driven by its technology segment's exposure to agentic AI following its acquisition of Exela. These ratings suggest strong conviction in the upside potential of both companies despite broader market caution regarding healthcare IT. Overall, the firm's analysis highlights strategic value in both established providers and emerging tech-driven turnarounds.